1.Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, et al: Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2197–2223.
2.Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M, Bridgett L, Williams S, Guillemin F, Hill CL, et al: The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis 2014, 73:1323–1330.
3.Tallon D, Chard J, Dieppe P: Exploring the priorities of patients with osteoarthritis of the knee. Arthritis Care Res 2000, 13:312–319.
4.Conaghan PG, Peloso PM, Everett SV, Rajagopalan S, Black CM, Mavros P, Arden NK, Phillips CJ, Rannou F, van de Laar MA, et al: Inadequate pain relief and large functional loss among patients with knee osteoarthritis: evidence from a prospective multinational longitudinal study of osteoarthritis real-world therapies. Rheumatology (Oxford) 2015, 54:270–277.
5.Lane NE, Brandt K, Hawker G, Peeva E, Schreyer E, Tsuji W, Hochberg MC: OARSI-FDA initiative: defining the disease state of osteoarthritis. Osteoarthritis Cartilage 2011, 19:478–482.
6.Jones G: Sources of pain in osteoarthritis: Implications for therapy. Int J Clin Rheumatol 2013, 8:335–345.
7.Spector TD, Hart DJ, Nandra D, Doyle DV, Mackillop N, Gallimore JR, Pepys MB: Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. Arthritis and Rheumatism 1997, 40:723–727.
8.Scanzello CR, Goldring SR: The role of synovitis in osteoarthritis pathogenesis. Bone 2012, 51:249–257.
9.Deveza LA, Melo L, Yamato TP, Mills K, Ravi V, Hunter DJ: Knee osteoarthritis phenotypes and their relevance for outcomes: a systematic review. Osteoarthritis Cartilage 2017, 25:1926–1941.
10.Jin X, Beguerie JR, Zhang W, Blizzard L, Otahal P, Jones G, Ding C: Circulating C reactive protein in osteoarthritis: a systematic review and meta-analysis. Ann Rheum Dis 2015, 74:703–710.
11.Pearle AD, Scanzello CR, George S, Mandl LA, DiCarlo EF, Peterson M, Sculco TP, Crow MK: Elevated high-sensitivity C-reactive protein levels are associated with local inflammatory findings in patients with osteoarthritis. Osteoarthritis Cartilage 2007, 15:516–523.
12.Stannus OP, Jones G, Blizzard L, Cicuttini FM, Ding C: Associations between serum levels of inflammatory markers and change in knee pain over 5 years in older adults: a prospective cohort study. Ann Rheum Dis 2013, 72:535–540.
13.Hanna FS, Bell RJ, Cicuttini FM, Davison SL, Wluka AE, Davis SR: High sensitivity C-reactive protein is associated with lower tibial cartilage volume but not lower patella cartilage volume in healthy women at mid-life. Arthritis Res Ther 2008, 10:R27.
14.Sharif M, Shepstone L, Elson CJ, Dieppe PA, Kirwan JR: Increased serum C reactive protein may reflect events that precede radiographic progression in osteoarthritis of the knee. Annals of the Rheumatic Diseases 2000, 59:71–74.
15.Yusuf E, Kortekaas MC, Watt I, Huizinga TW, Kloppenburg M: Do knee abnormalities visualised on MRI explain knee pain in knee osteoarthritis? A systematic review. Ann Rheum Dis 2011, 70:60–67.
16.Hill CL, Hunter DJ, Niu J, Clancy M, Guermazi A, Genant H, Gale D, Grainger A, Conaghan P, Felson DT: Synovitis detected on magnetic resonance imaging and its relation to pain and cartilage loss in knee osteoarthritis. Ann Rheum Dis 2007, 66:1599–1603.
17.Zhang Y, Nevitt M, Niu J, Lewis C, Torner J, Guermazi A, Roemer F, McCulloch C, Felson DT: Fluctuation of knee pain and changes in bone marrow lesions, effusions, and synovitis on magnetic resonance imaging. Arthritis Rheum 2011, 63:691–699.
18.Wang X, Jin X, Han W, Cao Y, Halliday A, Blizzard L, Pan F, Antony B, Cicuttini F, Jones G, Ding C: Cross-sectional and longitudinal associations between knee joint effusion synovitis and knee pain in older adults. J Rheumatol 2016, 43:121–130.
19.Wang X, Blizzard L, Halliday A, Han W, Jin X, Cicuttini F, Jones G, Ding C: Association between MRI-detected knee joint regional effusion-synovitis and structural changes in older adults: a cohort study. Ann Rheum Dis 2014.
20.Conaghan PG, D’Agostino MA, Le Bars M, Baron G, Schmidely N, Wakefield R, Ravaud P, Grassi W, Martin-Mola E, So A, et al: Clinical and ultrasonographic predictors of joint replacement for knee osteoarthritis: results from a large, 3-year, prospective EULAR study. Ann Rheum Dis 2010, 69:644–647.
21.Abou-Raya A, Abou-Raya S, Khadrawi T, Helmii M: Effect of low-dose oral prednisolone on symptoms and systemic inflammation in older adults with moderate to severe knee osteoarthritis: a randomized placebo-controlled trial. J Rheumatol 2014, 41:53–59.
22.Aitken D, Laslett LL, Pan F, Haugen IK, Otahal P, Bellamy N, Bird P, Jones G: A randomised double-blind placebo-controlled crossover trial of HUMira (adalimumab) for erosive hand OsteoaRthritis - the HUMOR trial. Osteoarthritis Cartilage 2018, 26:880–887.
23.Goldberg RJ, Katz J: A meta-analysis of the analgesic effects of omega–3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain 2007, 129:210–223.
24.Fortin PR, Lew RA, Liang MH, Wright EA, Beckett LA, Chalmers TC, Sperling RI: Validation of a meta-analysis: the effects of fish oil in rheumatoid arthritis. J Clin Epidemiol 1995, 48:1379–1390.
25.Lee YH, Bae SC, Song GG: Omega–3 polyunsaturated fatty acids and the treatment of rheumatoid arthritis: a meta-analysis. Arch Med Res 2012, 43:356–362.
26.Proudman SM, James MJ, Spargo LD, Metcalf RG, Sullivan TR, Rischmueller M, Flabouris K, Wechalekar MD, Lee AT, Cleland LG: Fish oil in recent onset rheumatoid arthritis: a randomised, double-blind controlled trial within algorithm-based drug use. Ann Rheum Dis 2015, 74:89–95.
27.Baker KR, Matthan NR, Lichtenstein AH, Niu J, Guermazi A, Roemer F, Grainger A, Nevitt MC, Clancy M, Lewis CE, et al: Association of plasma n–6 and n–3 polyunsaturated fatty acids with synovitis in the knee: the MOST study. Osteoarthritis Cartilage 2012, 20:382–387.
28.Senftleber NK, Nielsen SM, Andersen JR, Bliddal H, Tarp S, Lauritzen L, Furst DE, Suarez-Almazor ME, Lyddiatt A, Christensen R: Marine oil supplements for arthritis pain: a systematic review and meta-analysis of randomized trials. Nutrients 2017, 9.
29.Hill CL, March LM, Aitken D, Lester SE, Battersby R, Hynes K, Fedorova T, Proudman SM, James M, Cleland LG, Jones G: Fish oil in knee osteoarthritis: a randomised clinical trial of low dose versus high dose. Ann Rheum Dis 2016, 75:23–29.
30.Tou JC, Jaczynski J, Chen YC: Krill for human consumption: nutritional value and potential health benefits. Nutr Rev 2007, 65:63–77.
31.Ulven SM, Kirkhus B, Lamglait A, Basu S, Elind E, Haider T, Berge K, Vik H, Pedersen JI: Metabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of EPA and DHA, in healthy volunteers. Lipids 2011, 46:37–46.
32.Ierna M, Kerr A, Scales H, Berge K, Griinari M: Supplementation of diet with krill oil protects against experimental rheumatoid arthritis. BMC Musculoskelet Disord 2010, 11:136.
33.Vigerust NF, Bjorndal B, Bohov P, Brattelid T, Svardal A, Berge RK: Krill oil versus fish oil in modulation of inflammation and lipid metabolism in mice transgenic for TNF-alpha. Eur J Nutr 2013, 52:1315–1325.
34.Deutsch L: Evaluation of the effect of Neptune Krill Oil on chronic inflammation and arthritic symptoms. J Am Coll Nutr 2007, 26:39–48.
35.Suzuki Y, Fukushima M, Sakuraba K, Sawaki K, Sekigawa K: Krill oil improves mild knee joint pain: A randomized control trial. PLoS ONE 2016, 11:e0162769.
36.Schulz KF, Altman DG, Moher D: CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med 2010, 152:726–732.
37.Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M, et al.: Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986, 29:1039–1049.
38.Wang X, Jin X, Blizzard L, Antony B, Han W, Zhu Z, Cicuttini F, Wluka AE, Winzenberg T, Jones G, Ding C: Associations Between Knee Effusion-synovitis and Joint Structural Changes in Patients with Knee Osteoarthritis. J Rheumatol 2017, 44:1644–1651.
39.Altman RD, Hochberg M, Murphy WA, Jr., Wolfe F, Lequesne M: Atlas of individual radiographic features in osteoarthritis. Osteoarthritis Cartilage 1995, 3:3–70.
40.Taves DR: Minimization: a new method of assigning patients to treatment and control groups. Clin Pharmacol Ther 1974, 15:443–453.
41.Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW: Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988, 15:1833–1840.
42.Kersten P, White PJ, Tennant A: The visual analogue WOMAC 3.0 scale—internal validity and responsiveness of the VAS version. BMC Musculoskelet Disord 2010, 11:80.
43.Bellamy N. WOMAC Osteoarthritis Index User Guide. Version XI. Brisbane, Australia, 2014. http://www.womac.org/womac/womac_userguide.htm.
44.Wang X, Blizzard L, Halliday A, Han W, Jin X, Cicuttini F, Jones G, Ding C: Association between MRI-detected knee joint regional effusion-synovitis and structural changes in older adults: a cohort study. Ann Rheum Dis 2016, 75:519–525.
45.Wang X, Cicuttini F, Jin X, Wluka AE, Han W, Zhu Z, Blizzard L, Antony B, Winzenberg T, Jones G, Ding C: Knee effusion-synovitis volume measurement and effects of vitamin D supplementation in patients with knee osteoarthritis. Osteoarthritis Cartilage 2017, 25:1304–1312.
46.Doré D, Martens A, Quinn S, Ding C, Winzenberg T, Zhai G, Pelletier JP, Martel-Pelletier J, Abram F, Cicuttini F, Jones G: Bone marrow lesions predict site-specific cartilage defect development and volume loss: a prospective study in older adults. Arthritis Res Ther 2010, 12:R222.
47.Laslett LL, Doré DA, Quinn SJ, Boon P, Ryan E, Winzenberg TM, Jones G: Zoledronic acid reduces knee pain and bone marrow lesions over 1 year: a randomised controlled trial. Ann Rheum Dis 2012, 71:1322–1328.
48.Doré D, Quinn S, Ding C, Winzenberg T, Zhai G, Cicuttini F, Jones G: Natural history and clinical significance of MRI-detected bone marrow lesions at the knee: a prospective study in community dwelling older adults. Arthritis Res Ther 2010, 12:R223.
49.Wakefield RJ, Balint PV, Szkudlarek M, Filippucci E, Backhaus M, D’Agostino MA, Sanchez EN, Iagnocco A, Schmidt WA, Bruyn GA, et al: Musculoskeletal ultrasound including definitions for ultrasonographic pathology. J Rheumatol 2005, 32:2485–2487.
50.Rolke R, Magerl W, Campbell KA, Schalber C, Caspari S, Birklein F, Treede RD: Quantitative sensory testing: a comprehensive protocol for clinical trials. Eur J Pain 2006, 10:77–88.
51.Pham T, van der Heijde D, Altman RD, Anderson JJ, Bellamy N, Hochberg M, Simon L, Strand V, Woodworth T, Dougados M: OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthritis Cartilage 2004, 12:389–399.
52.Laslett LL, Quinn SJ, Darian-Smith E, Kwok M, Fedorova T, Korner H, Steels E, March L, Jones G: Treatment with 4Jointz reduces knee pain over 12 weeks of treatment in patients with clinical knee osteoarthritis: a randomised controlled trial. Osteoarthritis Cartilage 2012, 20:1209–1216.
53.Jones G, Glisson M, Hynes K, Cicuttini F: Sex and site differences in cartilage development: a possible explanation for variations in knee osteoarthritis in later life. Arthritis Rheum 2000, 43:2543–2549.
54.Hawker GA, Davis AM, French MR, Cibere J, Jordan JM, March L, Suarez-Almazor M, Katz JN, Dieppe P: Development and preliminary psychometric testing of a new OA pain measure—an OARSI/OMERACT initiative. Osteoarthritis Cartilage 2008, 16:409–414.
55.Measure of Intermittent and Constant Osteoarthritis Pain: ICOAP User’s Guide [https://www.oarsi.org/sites/default/files/docs/2013/icoap_users_guide_07072010.pdf]
56.AQoL–6D [http://www.aqol.com.au/aqolquestionnaires/56.html]
57.Richardson JR, Peacock SJ, Hawthorne G, Iezzi A, Elsworth G, Day NA: Construction of the descriptive system for the Assessment of Quality of Life AQoL–6D utility instrument. Health Qual Life Outcomes 2012, 10:38.
58.Jones G, Ding C, Scott F, Glisson M, Cicuttini F: Early radiographic osteoarthritis is associated with substantial changes in cartilage volume and tibial bone surface area in both males and females. Osteoarthritis Cartilage 2004, 12:169–174.
59.Freynhagen R, Baron R, Gockel U, Tolle TR: painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin 2006, 22:1911–1920.
60.Lee JK, Grace KA, Foster TG, Crawley MJ, Erowele GI, Sun HJ, Turner PT, Sullenberger LE, Taylor AJ: How should we measure medication adherence in clinical trials and practice? Ther Clin Risk Manag 2007, 3:685–690.
61.Laslett LL, Quinn S, Darian-Smith E, Kwok M, Fedorova T, Körner H, Steels E, March L, Jones G: Treatment with 4Jointz reduces knee pain over 12 weeks of treatment in patients with clinical knee osteoarthritis: a randomised controlled trial. Osteoarthritis Cartilage 2012, 20:1209–1216.
62.Jin X, Jones G, Cicuttini F, Wluka A, Zhu Z, Han W, Antony B, Wang X, Winzenberg T, Blizzard L, Ding C: Effect of Vitamin D Supplementation on Tibial Cartilage Volume and Knee Pain Among Patients With Symptomatic Knee Osteoarthritis: A Randomized Clinical Trial. JAMA 2016, 315:1005–1013.
63.Stannus O, Jones G, Cicuttini F, Parameswaran V, Quinn S, Burgess J, Ding C: Circulating levels of IL–6 and TNF-alpha are associated with knee radiographic osteoarthritis and knee cartilage loss in older adults. Osteoarthritis Cartilage 2010, 18:1441–1447.
64.Wenham CY, Hensor EM, Grainger AJ, Hodgson R, Balamoody S, Dore CJ, Emery P, Conaghan PG: A randomized, double-blind, placebo-controlled trial of low-dose oral prednisolone for treating painful hand osteoarthritis. Rheumatology (Oxford) 2012, 51:2286–2294.
65.Wenham CY, Grainger AJ, Hensor EM, Caperon AR, Ash ZR, Conaghan PG: Methotrexate for pain relief in knee osteoarthritis: an open-label study. Rheumatology (Oxford) 2013, 52:888–892.